Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of CEM-102 compared to
Linezolid in the treatment of acute bacterial skin structure infections (ABSSIs).